Presagen co-founder forms new AI-powered drug discovery company
- David Brooks
- Dec 2, 2024
- 1 min read
Updated: Jun 5

Qubigen - accelerate drug design without exposing secrets.
Whether you're advancing active programs, reviving dormant data, or starting from scratch, Qubigen’s secure AI platform and virtual screening capabilities can help you identify, optimize, and accelerate the path to promising lead drug candidates. Get in touch to explore how we can support your next discovery.